Lin et al. (109) found increased levels of DAAO in the serum of patients with mild cognitive impairment (MCI) and AD and observed that the severity of cognitive deficits correlated positively with DAAO blood levels, suggesting that this enzyme catabolizing D-serine may also serve as a biomarker for MCI/AD. The gene discussed is DAO; the disease is Cognitive impairment.